ABBOTT TO SPIN OFF ITS NUTRITION BUSINESS AS A NEW PUBLIC COMPANY
The unit behind Ensure, PediaSure and Similac has about $8.5 billion in annual sales. Abbott shareholders will receive shares of the new company in a tax-free separation expected by the end of 2027, per Abbott